Receptor

A receptor is how a cell hears. It’s a protein — usually sitting on the cell’s surface — shaped to catch one particular kind of molecule. When the right molecule docks, the receptor changes shape and passes a message to the inside of the cell: do the thing.

The classic image is a lock and key. The receptor is the lock; the signaling molecule (a hormone, a neurotransmitter, or a peptide) is the key cut to fit it. Fit the wrong key and nothing happens. Fit the right one and the cell responds.

Receptors are the reason drugs can be selective. A peptide that only fits the GLP-1 receptor mostly leaves other systems alone, which is what makes it targeted rather than scattershot. It’s also why the same word keeps appearing next to agonist (something that fits and activates the receptor) and antagonist (something that fits and blocks it).

For a concrete example, take semaglutide: it is a GLP-1 receptor agonist, meaning it binds to that receptor and switches it on. The receptor does not care that the signal came from a medicine rather than the body’s own GLP-1; it responds to the molecular fit and carries the message into the cell. That activation changes several glucose-related signals, including increasing insulin release and lowering glucagon when blood glucose is high, so one receptor interaction can set off a chain of effects rather than a single isolated action. Calling semaglutide an agonist therefore tells you both where it acts and what it does once it gets there; the receptor is the target, while activation is the move.

For anyone reading up on peptides, the receptor is the destination. Almost every mechanism you’ll read — “acts on,” “binds,” “stimulates” — is describing a molecule finding its receptor and either flipping it on or holding it shut.